Uruguay on Tuesday released real-world data on the impact of Sinovac Biotech's Covid-19 vaccine among its population that showed it was over 90 percent effective in preventing intensive care admissions and deaths.

The shot reduced deaths by 95 percent and intensive care admissions by 92 percent, and also showed 61 percent efficacy in cutting coronavirus infections, the government said...